| Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse CM Karsten, Y Laumonnier, B Eurich, F Ender, K Bröker, S Roy, ... The Journal of Immunology 194 (4), 1841-1855, 2015 | 91 | 2015 |
| Unique IL-13Rα2/STAT3 mediated IL-13 regulation detected in lung conventional dendritic cells, 24 h post viral vector vaccination S Roy, HY Liu, MI Jaeson, LP Deimel, C Ranasinghe Scientific Reports 10 (1), 1017, 2020 | 26 | 2020 |
| Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes S Roy, MI Jaeson, Z Li, S Mahboob, RJ Jackson, B Grubor-Bauk, ... Vaccine 37 (10), 1266-1276, 2019 | 23 | 2019 |
| Impact of pre-existing immunity to influenza on live-attenuated influenza vaccine (LAIV) immunogenicity S Roy, CM Williams, DK Wijesundara, Y Furuya Vaccines 8 (4), 683, 2020 | 17 | 2020 |
| Unexpected involvement of IL‐13 signalling via a STAT6 independent mechanism during murine IgG2a development following viral vaccination MA Hamid, RJ Jackson, S Roy, M Khanna, C Ranasinghe European journal of immunology 48 (7), 1153-1163, 2018 | 17 | 2018 |
| STAT3 determines IL-4 signalling outcomes in naive T cells LP Deimel, Z Li, S Roy, C Ranasinghe Scientific reports 11 (1), 10495, 2021 | 14 | 2021 |
| The Interleukin-33–Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine CM Williams, S Roy, D Califano, ANJ McKenzie, DW Metzger, Y Furuya Journal of virology 95 (22), 10.1128/jvi. 00598-21, 2021 | 13 | 2021 |
| PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion JL Hope, DC Otero, EA Bae, CJ Stairiker, AB Palete, HA Faso, M Lin, ... Cell reports 42 (5), 2023 | 7 | 2023 |
| Impact of pre-existing immunity on live attenuated influenza vaccine-induced cross-protective immunity S Roy, CM Williams, J Pardo, DK Wijesundara, Y Furuya Vaccines 8 (3), 459, 2020 | 7 | 2020 |
| IL-4 and IL-13 Receptors C Ranasinghe, S Roy, Z Li, M Khanna, RJ Jackson Encyclopedia of Signaling Molecules. Springer International Publishing, 2549 …, 2018 | 5 | 2018 |
| LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza CM Williams, S Roy, W Sun, AM Furuya, DK Wijesundara, Y Furuya Clinical & Translational Immunology 11 (3), e1381, 2022 | 2 | 2022 |
| IL-13Rα2 regulates the IL-13/IFN-γ balance during innate lymphoid cell and dendritic cell responses to pox viral vector-based vaccination Z Li, S Roy, C Ranasinghe Vaccines 9 (5), 440, 2021 | 1 | 2021 |
| Evaluation of Innate Lymphoid Cells and Dendritic CellsDendritic cellsVaccinationInnate lymphoid cells Following Viral Vector Vaccination Z Li, S Roy, C Ranasinghe Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols …, 2022 | | 2022 |
| Detrimental impact of allergic airway disease on live attenuated influenza vaccine S Roy, CM Williams, Y Furuya Health Science Reports 4 (3), 2021 | | 2021 |
| A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial Infection S Roberts, CM Williams, S Roy, Y Furuya Bio-protocol 10 (8), e3583-e3583, 2020 | | 2020 |
| Impact of viral vectors on vaccine design: IL-13Ra2 in DC regulation S Roy The Australian National University, 2020 | | 2020 |
